scispace - formally typeset
H

Haldun Muderrisoglu

Researcher at Başkent University

Publications -  357
Citations -  6057

Haldun Muderrisoglu is an academic researcher from Başkent University. The author has contributed to research in topics: Coronary artery disease & Coronary flow reserve. The author has an hindex of 37, co-authored 349 publications receiving 5538 citations. Previous affiliations of Haldun Muderrisoglu include Atılım University & Hacettepe University.

Papers
More filters
Journal ArticleDOI

Epicardial adipose tissue thickness by echocardiography is a marker for the presence and severity of coronary artery disease.

TL;DR: EAT thickness, which is easily and non-invasively evaluated by transthoracic echocardiography, can be an adjunctive marker to classical risk factors for the prediction of CAD.
Journal ArticleDOI

Relation between epicardial fat thickness and coronary flow reserve in women with chest pain and angiographically normal coronary arteries

TL;DR: EFT has the potential to be an additional and easy diagnostic tool for risk stratification of women with chest pain and angiographically normal coronary arteries and emerged as the only independent predictor of microvascular dysfunction.
Journal ArticleDOI

Low serum bilirubin levels are independently and inversely related to impaired flow-mediated vasodilation and increased carotid intima-media thickness in both men and women.

TL;DR: The healthy subjects with lower serum bilirubin concentrations show significant ED and increased carotid IMT, which are predictors for atherosclerosis.
Journal ArticleDOI

Relationship of serum uric acid to measures of endothelial function and atherosclerosis in healthy adults

TL;DR: High brachial artery resting diameter, FMD, carotid IMT, AoD, AoSI and AoEM were studied in healthy subjects with UA concentrations in physiological range for predictors for development and/or progression of atherosclerosis.
Journal ArticleDOI

Diabetes and cardiac autonomic neuropathy: Clinical manifestations, cardiovascular consequences, diagnosis and treatment.

TL;DR: Medical therapies, including aldose reductase inhibitors, angiotensin-converting enzyme inhibitors, prostoglandin analogs and alpha-lipoic acid, have been found to be effective in randomized controlled trials.